Opportunity Information: Apply for RFA AA 23 004
The Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional) funding opportunity (RFA-AA-23-004) is a National Institutes of Health (NIH) center-grant program led by the National Institute on Alcohol Abuse and Alcoholism (NIAAA). It is designed to support high-impact, coordinated research centers focused specifically on the intersection of alcohol use and HIV/AIDS. The overall aim is to generate findings that meaningfully improve HIV prevention, treatment outcomes, and long-term health for people affected by HIV, particularly where alcohol use (and related factors) makes HIV control more difficult. While clinical trials are optional under this announcement, the emphasis is on translational work that can move insights from mechanisms and real-world patterns into practical strategies, interventions, and implementation approaches.
A central theme of the announcement is that alcohol use is not being treated as a side issue, but as a major, modifiable driver that can influence nearly every stage of the HIV continuum. NIAAA is seeking research that clarifies how alcohol use, alcohol use disorder, and alcohol-related behaviors increase HIV acquisition risk, interfere with prevention tools (such as PrEP uptake and adherence), reduce treatment effectiveness (including ART adherence and viral suppression), and worsen HIV-related comorbidities. The FOA also explicitly highlights that alcohol-related impacts often occur alongside other substance use, mental health conditions, and medication or pharmacological complications. In practice, this means proposed centers are expected to address complex, overlapping realities that patients and communities face, rather than isolating alcohol from co-occurring challenges that can compound HIV risk and worsen clinical outcomes.
The opportunity is strongly aligned with federal HIV research and policy priorities, particularly the NIH Office of AIDS Research (OAR) Strategic Plan for HIV and HIV-Related Research (FY2021-FY2025) and the National HIV/AIDS Strategy (2022-2025). By referencing these frameworks, the announcement signals that responsive applications should be clearly connected to nationally prioritized HIV goals, including the broader push to end the HIV epidemic and to improve outcomes among populations disproportionately affected by HIV and substance use. A key point is that NIAAA is encouraging research that can help close gaps for substance users, including people whose alcohol use makes engagement in prevention or sustained treatment more difficult.
Structurally, this is a discretionary grant program in the health funding category (CFDA 93.273) using a center-style grant mechanism (P60). While the announcement text provided does not lay out the internal cores or project components, the intent of a research center grant is typically to support an integrated set of complementary projects under a unifying theme, leveraging shared resources, expertise, and infrastructure to produce results that would be difficult to achieve through isolated individual projects. In other words, the program is looking for a hub that can drive a coherent research agenda on alcohol and HIV/AIDS, rather than a single stand-alone study.
The eligible applicant pool is broad and includes many types of U.S.-based organizations: state, county, and local governments; special districts; independent school districts; public and private institutions of higher education; public housing authorities/Indian housing authorities; federally recognized tribal governments; other tribal organizations; nonprofits (with or without 501(c)(3) status); for-profit organizations other than small businesses; small businesses; and other eligible entities. The FOA also calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. On the foreign eligibility side, non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the applicant organization. However, non-domestic components of U.S. organizations are eligible, and foreign components (as NIH defines them) are allowed, which can matter for centers that need international field sites, collaborations, or specialized expertise while keeping the prime applicant organization U.S.-based.
Key dates and funding details included in the source information are that the opportunity was created on 2023-10-17, with an original closing date of 2024-04-18. The listed award ceiling is $1,200,000, indicating the maximum expected funding level per award under the ceiling specified in the opportunity record. The entry also notes “ExpectedAwards:” but does not provide a number in the excerpt, so applicants would need to consult the full FOA for the anticipated number of awards and any additional budget structure, project period expectations, or required center components.
In practical terms, the FOA is looking for research centers that can tackle the most consequential barriers to controlling and ultimately ending the HIV/AIDS pandemic where alcohol plays a meaningful role. Competitive applications will likely be those that clearly define the real-world HIV problem being addressed, explain how alcohol use and its related complications drive that problem, and propose a coordinated, translational research plan that can produce actionable outcomes for prevention, care, and comorbidity management in affected communities.Apply for RFA AA 23 004
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
- This funding opportunity was created on 2023-10-17.
- Applicants must submit their applications by 2024-04-18. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,200,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Modules for Enhancing Biomedical Research Workforce Training (R25 - Independent Clinical Trial Not Allowed)
Previous opportunity: F24AS00018 Rapid Response Fund for Aquatic Invasive Species
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AA 23 004
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AA 23 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional) Apply for RFA MD 24 001 Funding Number: RFA MD 24 001 Agency: National Institutes of Health Category: Health Funding Amount: $3,500,000 |
| Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed) Apply for RFA AG 24 040 Funding Number: RFA AG 24 040 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required) Apply for RFA NS 24 013 Funding Number: RFA NS 24 013 Agency: National Institutes of Health Category: Health Funding Amount: $6,700,000 |
| NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required) Apply for PAR 24 050 Funding Number: PAR 24 050 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) Apply for PAR 24 051 Funding Number: PAR 24 051 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs) (U01 Clinical Trial Not Allowed) Apply for RFA AI 23 059 Funding Number: RFA AI 23 059 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA AI 23 060 Funding Number: RFA AI 23 060 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R01-Clinical Trial Not Allowed) Apply for PAS 24 058 Funding Number: PAS 24 058 Agency: National Institutes of Health Category: Health Funding Amount: $499,999 |
| Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R21-Clinical Trial Not Allowed) Apply for PAS 24 057 Funding Number: PAS 24 057 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Sustaining Impact for Youth Activity Apply for 72052124RFA00001 Funding Number: 72052124RFA00001 Agency: Haiti USAID-Port Au Prince Category: Health Funding Amount: $30,000,000 |
| USAID/Kenya and East Africa Social Behavior Change Activity Apply for 72061524RFI00001 Funding Number: 72061524RFI00001 Agency: Kenya USAID-Nairobi Category: Health Funding Amount: $20,000,000 |
| USAID/Cambodia Community Mobilization Initiatives to End Tuberculosis 2 (COMMIT 2) Apply for RFI 442 24 001 Funding Number: RFI 442 24 001 Agency: Cambodia USAID-Phnom Penh Category: Health Funding Amount: $20,000,000 |
| IND-enabling Studies for Platform Clinical Trials of Genome Editing in Multiple Diseases (U01 Clinical Trial Not Allowed) Apply for RFA RM 24 001 Funding Number: RFA RM 24 001 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional) Apply for RFA MH 24 181 Funding Number: RFA MH 24 181 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional) Apply for RFA MH 24 180 Funding Number: RFA MH 24 180 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) Apply for PAR 23 282 Funding Number: PAR 23 282 Agency: National Institutes of Health Category: Health Funding Amount: $351,000 |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) Apply for PAR 24 049 Funding Number: PAR 24 049 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed) Apply for RFA HG 23 048 Funding Number: RFA HG 23 048 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) Apply for PAR 24 035 Funding Number: PAR 24 035 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) Apply for PAR 24 036 Funding Number: PAR 24 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AA 23 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
